HHM Wealth Advisors’s Haemonetics HAE Stock Holding History

HHM Wealth Advisors’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30K	Hold	400	–	–	﹤0.01%	462
2026 Q1	$22.5K	Hold	400	–	–	﹤0.01%	488
2025 Q4	$32.1K	Hold	400	–	–	﹤0.01%	426
2025 Q3	$19.5K	Hold	400	–	–	﹤0.01%	516
2025 Q2	$29.8K	Hold	400	–	–	﹤0.01%	448
2025 Q1	$25.4K	Hold	400	–	–	﹤0.01%	472
2024 Q4	$31.2K	Hold	400	–	–	﹤0.01%	431
2024 Q3	$32.2K	Hold	400	–	–	﹤0.01%	400
2024 Q2	$33.1K	Hold	400	–	–	0.01%	390
2024 Q1	$34.1K	Hold	400	–	–	0.01%	346
2023 Q4	$34.2K	Hold	400	–	–	0.01%	341
2023 Q3	$35.8K	Hold	400	–	–	0.01%	321
2023 Q2	$34.1K	Hold	400	–	–	0.01%	344
2023 Q1	$33.1K	Hold	400	–	–	0.01%	329
2022 Q4	$31.5K	Hold	400	–	–	0.01%	300
2022 Q3	$30K	Hold	400	–	–	0.01%	300
2022 Q2	$26K	Hold	400	–	–	0.01%	386
2022 Q1	$25K	Buy	+400	New	+$21.8K	0.01%	407

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HHM Wealth Advisors's HAE Position: Q2 2026 in Review

HHM Wealth Advisors held its Haemonetics (HAE) position steady in Q2 2026 at 400 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #462.

HHM Wealth Advisors first reported a position in HAE in Q1 2022 and has held it in 18 quarters since. The position peaked at $35.8K in Q3 2023. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

HHM Wealth Advisors held 400 shares of Haemonetics worth $30K as of Q2 2026.
HHM Wealth Advisors left its Haemonetics share count unchanged in Q2 2026.
Haemonetics made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #462 holding.
HHM Wealth Advisors first reported a position in Haemonetics in Q1 2022 and has held it in 18 quarters since.
HHM Wealth Advisors's Haemonetics position peaked at $35.8K in Q3 2023.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.